{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:53:02Z","timestamp":1793962382977,"version":"4.8.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81402396"],"award-info":[{"award-number":["81402396"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773119"],"award-info":[{"award-number":["81773119"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sichuan Science-Technology Soft Sciences Project","award":["2016ZR0086"],"award-info":[{"award-number":["2016ZR0086"]}]},{"name":"Yi Yao Foundation","award":["14H0563"],"award-info":[{"award-number":["14H0563"]}]},{"name":"Direct Scientific Research Grants from West China Second Hospital, Sichuan University","award":["KS021"],"award-info":[{"award-number":["KS021"]}]},{"name":"National Key R&D Program of China","award":["2017YFA0106800"],"award-info":[{"award-number":["2017YFA0106800"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Biol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13059-018-1412-6","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T04:27:25Z","timestamp":1522816045000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["The RNA binding protein SORBS2 suppresses metastatic colonization of ovarian cancer by stabilizing tumor-suppressive immunomodulatory transcripts"],"prefix":"10.1186","volume":"19","author":[{"given":"Linjie","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengnan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenlu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianxin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne Bond","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohua","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuquan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8322-5536","authenticated-orcid":false,"given":"Shengtao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,16]]},"reference":[{"key":"1412_CR1","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrc4019","volume":"15","author":"DD Bowtell","year":"2015","unstructured":"Bowtell DD, Bohm S, Ahmed AA, Aspuria PJ, Bast RC Jr, Beral V, Berek JS, Birrer MJ, Blagden S, Bookman MA, et al. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer. Nat Rev Cancer. 2015;15:668\u201379.","journal-title":"Nat Rev Cancer"},{"key":"1412_CR2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrc.2016.113","volume":"17","author":"AN Karnezis","year":"2017","unstructured":"Karnezis AN, Cho KR, Gilks CB, Pearce CL, Huntsman DG. The disparate origins of ovarian cancers: pathogenesis and prevention strategies. Nat Rev Cancer. 2017;17:65\u201374.","journal-title":"Nat Rev Cancer"},{"key":"1412_CR3","doi-asserted-by":"crossref","first-page":"16061","DOI":"10.1038\/nrdp.2016.61","volume":"2","author":"UA Matulonis","year":"2016","unstructured":"Matulonis UA, Sood AK, Fallowfield L, Howitt BE, Sehouli J, Karlan BY. Ovarian cancer. Nat Rev Dis Primers. 2016;2:16061.","journal-title":"Nat Rev Dis Primers"},{"key":"1412_CR4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.canlet.2016.04.038","volume":"377","author":"Z Luo","year":"2016","unstructured":"Luo Z, Wang Q, Lau WB, Lau B, Xu L, Zhao L, Yang H, Feng M, Xuan Y, Yang Y, et al. Tumor microenvironment: The culprit for ovarian cancer metastasis? Cancer Lett. 2016;377:174\u201382.","journal-title":"Cancer Lett"},{"key":"1412_CR5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nri3789","volume":"15","author":"T Kitamura","year":"2015","unstructured":"Kitamura T, Qian BZ, Pollard JW. Immune cell promotion of metastasis. Nat Rev Immunol. 2015;15:73\u201386.","journal-title":"Nat Rev Immunol"},{"key":"1412_CR6","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nri1961","volume":"6","author":"GP Dunn","year":"2006","unstructured":"Dunn GP, Koebel CM, Schreiber RD. Interferons, immunity and cancer immunoediting. Nat Rev Immunol. 2006;6:836\u201348.","journal-title":"Nat Rev Immunol"},{"key":"1412_CR7","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cell.2017.07.025","volume":"170","author":"A Jimenez-Sanchez","year":"2017","unstructured":"Jimenez-Sanchez A, Memon D, Pourpe S, Veeraraghavan H, Li Y, Vargas HA, Gill MB, Park KJ, Zivanovic O, Konner J, et al. Heterogeneous tumor-immune microenvironments among differentially growing metastases in an ovarian cancer patient. Cell. 2017;170:927\u201338.","journal-title":"Cell"},{"key":"1412_CR8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1158\/1078-0432.CCR-16-0081","volume":"23","author":"A Montfort","year":"2017","unstructured":"Montfort A, Pearce O, Maniati E, Vincent BG, Bixby L, Bohm S, Dowe T, Wilkes EH, Chakravarty P, Thompson R, et al. A strong B-cell response is part of the immune landscape in human high-grade serous ovarian metastases. Clin Cancer Res. 2017;23:250\u201362.","journal-title":"Clin Cancer Res"},{"key":"1412_CR9","first-page":"71","volume":"2","author":"NJ Bowen","year":"2009","unstructured":"Bowen NJ, Walker LD, Matyunina LV, Logani S, Totten KA, Benigno BB, McDonald JF. Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells. BMC Med Genet. 2009;2:71. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE14407","journal-title":"BMC Med Genet"},{"key":"1412_CR10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094476","volume":"9","author":"AS Brodsky","year":"2014","unstructured":"Brodsky AS, Fischer A, Miller DH, Vang S, MacLaughlan S, Wu HT, Yu J, Steinhoff M, Collins C, Smith PJ, et al. Expression profiling of primary and metastatic ovarian tumors reveals differences indicative of aggressive disease. PLoS One. 2014;9:e94476. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE30587","journal-title":"PLoS One"},{"key":"1412_CR11","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1038\/onc.2014.178","volume":"34","author":"S Condello","year":"2015","unstructured":"Condello S, Morgan CA, Nagdas S, Cao L, Turek J, Hurley TD, Matei D. beta-catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids. Oncogene. 2015;34:2297\u2013308. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE53759","journal-title":"Oncogene"},{"key":"1412_CR12","doi-asserted-by":"crossref","first-page":"43843","DOI":"10.18632\/oncotarget.5983","volume":"6","author":"TZ Tan","year":"2015","unstructured":"Tan TZ, Yang H, Ye J, Low J, Choolani M, Tan DS, Thiery JP, Huang RY. CSIOVDB: a microarray gene expression database of epithelial ovarian cancer subtype. Oncotarget. 2015;6:43843\u201352.","journal-title":"Oncotarget"},{"key":"1412_CR13","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","volume":"14","author":"RW Tothill","year":"2008","unstructured":"Tothill RW, Tinker AV, George J, Brown R, Fox SB, Lade S, Johnson DS, Trivett MK, Etemadmoghadam D, Locandro B, et al. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res. 2008;14:5198\u2013208. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE9891 ; https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE9891 .","journal-title":"Clin Cancer Res"},{"key":"1412_CR14","doi-asserted-by":"crossref","unstructured":"Integrated genomic analyses of ovarian carcinoma. Nature 2011, 474:609\u2013615. https:\/\/cancergenome.nih.gov\/ .","DOI":"10.1038\/nature10166"},{"key":"1412_CR15","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1101\/gad.270645.115","volume":"30","author":"L Fish","year":"2016","unstructured":"Fish L, Pencheva N, Goodarzi H, Tran H, Yoshida M, Tavazoie SF. Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts. Genes Dev. 2016;30:386\u201398.","journal-title":"Genes Dev"},{"key":"1412_CR16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrclinonc.2015.225","volume":"13","author":"RL Coleman","year":"2016","unstructured":"Coleman RL. Ovarian cancer in 2015: Insights into strategies for optimizing ovarian cancer care. Nat Rev Clin Oncol. 2016;13:71\u20132.","journal-title":"Nat Rev Clin Oncol"},{"key":"1412_CR17","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.tibs.2015.08.012","volume":"40","author":"S Calabretta","year":"2015","unstructured":"Calabretta S, Richard S. Emerging roles of disordered sequences in RNA-binding proteins. Trends Biochem Sci. 2015;40:662\u201372.","journal-title":"Trends Biochem Sci"},{"key":"1412_CR18","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1074\/jbc.M114.610725","volume":"290","author":"PV Anekal","year":"2015","unstructured":"Anekal PV, Yong J, Manser E. Arg kinase-binding protein 2 (ArgBP2) interaction with alpha-actinin and actin stress fibers inhibits cell migration. J Biol Chem. 2015;290:2112\u201325.","journal-title":"J Biol Chem"},{"key":"1412_CR19","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1523\/JNEUROSCI.2528-15.2016","volume":"36","author":"Q Zhang","year":"2016","unstructured":"Zhang Q, Gao X, Li C, Feliciano C, Wang D, Zhou D, Mei Y, Monteiro P, Anand M, Itohara S, et al. Impaired dendritic development and memory in Sorbs2 knock-out mice. J Neurosci. 2016;36:2247\u201360.","journal-title":"J Neurosci"},{"key":"1412_CR20","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.bbrc.2015.10.059","volume":"467","author":"Y Tong","year":"2015","unstructured":"Tong Y, Li Y, Gu H, Wang C, Liu F, Shao Y, Li J, Cao L, Li F. Microchidia protein 2, MORC2, downregulates the cytoskeleton adapter protein, ArgBP2, via histone methylation in gastric cancer cells. Biochem Biophys Res Commun. 2015;467:821\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"1412_CR21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.yjmcc.2016.03.014","volume":"94","author":"H Wang","year":"2016","unstructured":"Wang H, Bei Y, Shen S, Huang P, Shi J, Zhang J, Sun Q, Chen Y, Yang Y, Xu T, et al. miR-21-3p controls sepsis-associated cardiac dysfunction via regulating SORBS2. J Mol Cell Cardiol. 2016;94:43\u201353.","journal-title":"J Mol Cell Cardiol"},{"key":"1412_CR22","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1101\/gr.190660.115","volume":"25","author":"JD Robin","year":"2015","unstructured":"Robin JD, Ludlow AT, Batten K, Gaillard MC, Stadler G, Magdinier F, Wright WE, Shay JW. SORBS2 transcription is activated by telomere position effect-over long distance upon telomere shortening in muscle cells from patients with facioscapulohumeral dystrophy. Genome Res. 2015;25:1781\u201390.","journal-title":"Genome Res"},{"key":"1412_CR23","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1042\/BST0391455","volume":"39","author":"SJ Ressler","year":"2011","unstructured":"Ressler SJ, Rowley DR. The WFDC1 gene: role in wound response and tissue homoeostasis. Biochem Soc Trans. 2011;39:1455\u20139.","journal-title":"Biochem Soc Trans"},{"key":"1412_CR24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/carcin\/bgn232","volume":"30","author":"S Madar","year":"2009","unstructured":"Madar S, Brosh R, Buganim Y, Ezra O, Goldstein I, Solomon H, Kogan I, Goldfinger N, Klocker H, Rotter V. Modulated expression of WFDC1 during carcinogenesis and cellular senescence. Carcinogenesis. 2009;30:20\u20137.","journal-title":"Carcinogenesis"},{"key":"1412_CR25","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4049\/jimmunol.169.2.642","volume":"169","author":"T Starnes","year":"2002","unstructured":"Starnes T, Broxmeyer HE, Robertson MJ, Hromas R. Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J Immunol. 2002;169:642\u20136.","journal-title":"J Immunol"},{"key":"1412_CR26","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.celrep.2014.03.073","volume":"7","author":"T O'Sullivan","year":"2014","unstructured":"O'Sullivan T, Saddawi-Konefka R, Gross E, Tran M, Mayfield SP, Ikeda H, Bui JD. Interleukin-17D mediates tumor rejection through recruitment of natural killer cells. Cell Rep. 2014;7:989\u201398.","journal-title":"Cell Rep"},{"key":"1412_CR27","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1016\/j.ajpath.2014.07.013","volume":"184","author":"SJ Ressler","year":"2014","unstructured":"Ressler SJ, Dang TD, Wu SM, Tse DY, Gilbert BE, Vyakarnam A, Yang F, Schauer IG, Barron DA, Rowley DR. WFDC1 is a key modulator of inflammatory and wound repair responses. Am J Pathol. 2014;184:2951\u201364.","journal-title":"Am J Pathol"},{"key":"1412_CR28","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1016\/j.celrep.2016.07.075","volume":"16","author":"R Saddawi-Konefka","year":"2016","unstructured":"Saddawi-Konefka R, Seelige R, Gross ET, Levy E, Searles SC, Washington A Jr, Santosa EK, Liu B, O'Sullivan TE, Harismendy O, Bui JD. Nrf2 induces IL-17D to mediate tumor and virus surveillance. Cell Rep. 2016;16:2348\u201358.","journal-title":"Cell Rep"},{"key":"1412_CR29","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.cell.2012.04.031","volume":"149","author":"A Castello","year":"2012","unstructured":"Castello A, Fischer B, Eichelbaum K, Horos R, Beckmann BM, Strein C, Davey NE, Humphreys DT, Preiss T, Steinmetz LM, et al. Insights into RNA biology from an atlas of mammalian mRNA-binding proteins. Cell. 2012;149:1393\u2013406.","journal-title":"Cell"},{"key":"1412_CR30","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.molcel.2012.05.021","volume":"46","author":"AG Baltz","year":"2012","unstructured":"Baltz AG, Munschauer M, Schwanhausser B, Vasile A, Murakawa Y, Schueler M, Youngs N, Penfold-Brown D, Drew K, Milek M, et al. The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. Mol Cell. 2012;46:674\u201390.","journal-title":"Mol Cell"},{"key":"1412_CR31","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nature12311","volume":"499","author":"D Ray","year":"2013","unstructured":"Ray D, Kazan H, Cook KB, Weirauch MT, Najafabadi HS, Li X, Gueroussov S, Albu M, Zheng H, Yang A, et al. A compendium of RNA-binding motifs for decoding gene regulation. Nature. 2013;499:172\u20137.","journal-title":"Nature"},{"key":"1412_CR32","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nsmb.2638","volume":"20","author":"SC Kwon","year":"2013","unstructured":"Kwon SC, Yi H, Eichelbaum K, Fohr S, Fischer B, You KT, Castello A, Krijgsveld J, Hentze MW, Kim VN. The RNA-binding protein repertoire of embryonic stem cells. Nat Struct Mol Biol. 2013;20:1122\u201330.","journal-title":"Nat Struct Mol Biol"},{"key":"1412_CR33","doi-asserted-by":"crossref","first-page":"D301","DOI":"10.1093\/nar\/gkq1069","volume":"39","author":"KB Cook","year":"2011","unstructured":"Cook KB, Kazan H, Zuberi K, Morris Q, Hughes TR. RBPDB: a database of RNA-binding specificities. Nucleic Acids Res. 2011;39:D301\u20138.","journal-title":"Nucleic Acids Res"},{"key":"1412_CR34","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1158\/0008-5472.CAN-16-1615","volume":"77","author":"L Zhao","year":"2017","unstructured":"Zhao L, Ji G, Le X, Wang C, Xu L, Feng M, Zhang Y, Yang H, Xuan Y, Yang Y, et al. Long noncoding RNA LINC00092 acts in cancer-associated fibroblasts to drive glycolysis and progression of ovarian cancer. Cancer Res. 2017;77:1369\u201382.","journal-title":"Cancer Res"},{"key":"1412_CR35","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1038\/onc.2016.487","volume":"36","author":"L Zhao","year":"2017","unstructured":"Zhao L, Ji G, Le X, Luo Z, Wang C, Feng M, Xu L, Zhang Y, Lau WB, Lau B, et al. An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis. Oncogene. 2017;36:3384\u201396.","journal-title":"Oncogene"},{"key":"1412_CR36","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1093\/humrep\/det042","volume":"28","author":"L Zhao","year":"2013","unstructured":"Zhao L, Zhou S, Zou L, Zhao X. The expression and functionality of stromal caveolin 1 in human adenomyosis. Hum Reprod. 2013;28:1324\u201338.","journal-title":"Hum Reprod"},{"key":"1412_CR37","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.cell.2012.12.006","volume":"152","author":"Y Yu","year":"2013","unstructured":"Yu Y, Chen Y, Kim B, Wang H, Zhao C, He X, Liu L, Liu W, Wu LM, Mao M, et al. Olig2 targets chromatin remodelers to enhancers to initiate oligodendrocyte differentiation. Cell. 2013;152:248\u201361.","journal-title":"Cell"},{"key":"1412_CR38","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ccell.2015.09.009","volume":"28","author":"IG Cannell","year":"2015","unstructured":"Cannell IG, Merrick KA, Morandell S, Zhu CQ, Braun CJ, Grant RA, Cameron ER, Tsao MS, Hemann MT, Yaffe MB. A pleiotropic RNA-binding protein controls distinct cell cycle checkpoints to drive resistance of p53-defective tumors to chemotherapy. Cancer Cell. 2015;28:623\u201337.","journal-title":"Cancer Cell"},{"key":"1412_CR39","doi-asserted-by":"crossref","unstructured":"Zhao L, Wang W, Huang S, Yang Z, Xu L, Yang Q, Zhou X, Wang J, Shen Q, Wang C, Le X, et al. The RNA binding protein SORBS2 suppresses metastatic colonization of ovarian cancer by stabilizing tumor-suppressive immunomodulatory transcripts. Genome Biology. 2018.","DOI":"10.1186\/s13059-018-1412-6"},{"key":"1412_CR40","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1158\/1541-7786.MCR-08-0193","volume":"6","author":"MS Anglesio","year":"2008","unstructured":"Anglesio MS, Arnold JM, George J, Tinker AV, Tothill R, Waddell N, Simms L, Locandro B, Fereday S, Traficante N, et al. Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors. Mol Cancer Res. 2008;6:1678\u201390. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE12172","journal-title":"Mol Cancer Res"},{"key":"1412_CR41","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ygyno.2004.11.039","volume":"96","author":"CB Gilks","year":"2005","unstructured":"Gilks CB, Vanderhyden BC, Zhu S, van de Rijn M, Longacre TA. Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling. Gynecol Oncol. 2005;96:684\u201394. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE3208","journal-title":"Gynecol Oncol"}],"container-title":["Genome Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13059-018-1412-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T00:29:38Z","timestamp":1604104178000},"score":1,"resource":{"primary":{"URL":"https:\/\/genomebiology.biomedcentral.com\/articles\/10.1186\/s13059-018-1412-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,16]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1412"],"URL":"https:\/\/doi.org\/10.1186\/s13059-018-1412-6","relation":{},"ISSN":["1474-760X"],"issn-type":[{"value":"1474-760X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,16]]},"article-number":"35"}}